CD22 +
About
Biomarker type: Protein expression
Marker: CD22
Unit: status
Equality: =
Value: Positive
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (2) FDA (1) | CD22 + | Acute Lymphoid Leukemia | Inotuzumab ozogamicin | |
| EMA (2) | CD22 +, not BCR::ABL1 | Acute Lymphoid Leukemia | Inotuzumab ozogamicin |